Benutzer: Gast  Login
Mehr Felder
Einfache Suche
Titel:

A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook.

Dokumenttyp:
Journal Article; Review
Autor(en):
Kramvis, Anna; Chang, Kyong-Mi; Dandri, Maura; Farci, Patrizia; Glebe, Dieter; Hu, Jianming; Janssen, Harry L A; Lau, Daryl T Y; Penicaud, Capucine; Pollicino, Teresa; Testoni, Barbara; Van Bömmel, Florian; Andrisani, Ourania; Beumont-Mauviel, Maria; Block, Timothy M; Chan, Henry L Y; Cloherty, Gavin A; Delaney, William E; Geretti, Anna Maria; Gehring, Adam; Jackson, Kathy; Lenz, Oliver; Maini, Mala K; Miller, Veronica; Protzer, Ulrike; Yang, Jenny C; Yuen, Man-Fung; Zoulim, Fabien; Revill, Pete...     »
Abstract:
Globally, 296 million people are infected with hepatitis B virus (HBV), and approximately one million people die annually from HBV-related causes, including liver cancer. Although there is a preventative vaccine and antiviral therapies suppressing HBV replication, there is no cure. Intensive efforts are under way to develop curative HBV therapies. Currently, only a few biomarkers are available for monitoring or predicting HBV disease progression and treatment response. As new therapies become av...     »
Zeitschriftentitel:
Nat Rev Gastroenterol Hepatol
Jahr:
2022
Band / Volume:
19
Heft / Issue:
11
Seitenangaben Beitrag:
727-745
Volltext / DOI:
doi:10.1038/s41575-022-00649-z
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/35859026
Print-ISSN:
1759-5045
TUM Einrichtung:
Institut für Virologie (Prof. Protzer)
 BibTeX